FindTrial
Sign In

To study the effectiveness of combined oral contraceptives(drugs with female hormones) and myoinositol (drug that reduces insulin resistance) with life style modifications in adolescent and young female with Polycystic Ovarian Syndrome( disease with multiple cysts in ovary)

To study the effectiveness of combined oral contraceptive pills and myoinositol with life style modification in adolescent and young women with polycystic ovarian syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/05/014055
Enrollment
45
Registered
2018-05-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients who are diagnosed case of Polycystic Ovarian Syndrome

Interventions

Intervention1: GROUP C: paients with polycystic ovarian syndrome will be given both combined oral contraceptives and myoinositol along with life style modification in group C Intervention2: Group A: p

Sponsors

Khushbu Pandey
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects fulfilling Rotterdam criteria menstrual irregularity ( History of oligo or amenorrhea) signs of hyperandrogenism ( acne , hirsuitism , central alopecia ) signs of hyperinsulinemia ( obesity ,acanthosis nigricans )

Exclusion criteria

Exclusion criteria: Pregnancy Hypothyroidism Hyperprolactinemia Adrenal hyperandrogenemia Cushing Syndrome Patients within two years of menarche

Design outcomes

Primary

MeasureTime frame
to study the effectiveness of combined oral contraceptives and myoinositol as single therapy and in combination therapy with life style modification in adolescent and young women with polycystic ovarian syndromeTimepoint: three months—

Secondary

MeasureTime frame
Clinical response in terms of improvement in clinical symptoms and side effects Anthropometric change in weight, Basal Metabolic rate Change in hormonal parameters Timepoint: 0 months ( baseline) and 3 months—

Countries

India

Contacts

Public ContactSujata Deo

King Georges Medical University

drkhushbu.pandey@gmail.com9450529929

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026